Sign in
4

Changes in Ownership

Entrada Therapeutics, Inc. Filed Acc 0001104659-22-097872

President and CEO acquired 15,125 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Doshi Dipal · President and CEO

Table I: Non-derivative

1 line
Date Transaction Shares Owned after D/I
2022-09-01 Grant or award : show line 1 in the form +15,125 221,835 D
Loading xslF345X03/tm2225276-5_4seq1.xml…